Physician Assistant in Trophy Club, TX Accepting Medicare

2 Physician Assistant nurses found. Showing 1 - 2

Carol A Addy, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 945 Trophy Club Dr, Trophy Club, TX 76262 Phone: 817-430-9111    Fax: 817-430-8911

Ms. Sandy L Stetz, P.A.-C., M.ED. Physician Assistant Medicare: Medicare Enrolled Practice Location: 301 Trophy Lake Dr Unit 136, Trophy Club, TX 76262 Phone: 817-430-9111    Fax: 817-430-8911

News Archive

DURATION-4 study tests superiority of BYDUREON as compared to other type 2 diabetes medications

Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes, Inc. today announced results from DURATION-4, the fourth in a series of studies designed to test the superiority of BYDUREON (exenatide extended-release for injectable suspension), an investigational type 2 diabetes therapy, as compared to other type 2 diabetes medications.

Ethicon collaborates with Touch Surgery to deliver simulated surgical training for improving patient outcomes

Ethicon, Inc., part of the Johnson & Johnson Medical Devices Companies, announces a strategic collaboration with Touch Surgery to help improve patient outcomes by delivering simulated surgical training based on the safe and efficacious use of Ethicon products in a free mobile app that can reach medical professionals in even remote regions of the world.

Opinions: MDGs

"The overarching and noble goal [of this week's Millennium Development Goal (MDG) summit in New York] is reducing global poverty. But the most compelling and achievable objectives - huge reductions in maternal and child mortality worldwide - will be severely undermined if the Obama administration either directly or covertly integrates abortion into the final outcome document," Rep. Chris Smith (R-N.J.) writes in a Washington Post opinion piece.

PET scan distinguishes Alzheimer's from other dementia

A PET scan (positron emission tomography) that measures uptake of sugar in the brain significantly improves the accuracy of diagnosing a type of dementia often mistaken for Alzheimer's disease, a study led by a University of Utah dementia expert has found.

Phase I study of selumetinib drug shows partial response in pediatric neural tumors

In an early-phase clinical trial of a new oral drug, selumetinib, children with the common genetic disorder neurofibromatosis type 1 (NF1) and plexiform neurofibromas, tumors of the peripheral nerves, tolerated selumetinib and, in most cases, responded to it with tumor shrinkage.

Read more Medical News

› Verified 6 days ago